Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001552622-19-000001
Filing Date
2019-11-08
Accepted
2019-11-07 19:48:47
Documents
1
Effectiveness Date
2019-11-08
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9495
  Complete submission text file 0001552622-19-000001.txt   10535
Mailing Address 39899 BALENTINE DRIVE, SUITE 185 NEWARK CA 94560
Business Address 39899 BALENTINE DRIVE, SUITE 185 NEWARK CA 94560 408-219-2576
InCarda Therapeutics, Inc. (Filer) CIK: 0001552622 (see all company filings)

IRS No.: 264521716 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-352920 | Film No.: 191201808